A 57-year-old lady with a history of familial paraganglioma syndrome type 4 with mutation in the succinate dehydrogenase complex, subunit B gene, had a nonfunctioning middle mediastinal paraganglioma. She also had a pituitary macroadenoma with elevated serum prolactin levels. Surgical excision of the highly vascular mediastinal tumor was performed after preparing the patient preoperatively with alpha blockers and strictly monitoring her blood pressure and blood sugar levels.
DeLellisRA (ed.). Pathology and Genetics of Tumours of Endocrine Organs.
IARC; 2004.
2.
FishbeinLMerrillSFrakerDLCohenDLNathansonKL.Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing.Ann Surg Oncol2013;
20: 1444–1450.
3.
GalanSRKannPH.Genetics and molecular pathogenesis of pheochromocytoma and paraganglioma.Clin Endocrinol (Oxf)2013;
78: 165–175.
4.
NeumannHPPawluCPęczkowskaM, et al.
Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.JAMA2004;
292: 943–951.
5.
ChenHSippelRSO’dorisioMSVinikAILloydRVPacakK.The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer.Pancreas2010;
39: 775–783.
6.
HuKPerskyMS.Multidisciplinary management of paragangliomas of the head and neck, Part 1. Oncology (Williston Park)2003;
17: 983–993.
7.
ProyeCFossatiPFontaineP, et al.
Dopamine-secreting pheochromocytoma: an unrecognized entity? Classification of pheochromocytomas according to their type of secretion.Surgery1986;
100: 1154–1162.
8.
JanssenIBlanchetEMAdamsK, et al.
Superiority of [68Ga]-DOTATATE PET/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma.Clin Cancer Res2015;
21: 3888–3895.
